⚠ Evidence warning: Clinical trials or other evidence do not support the claims that leucine with resistance training gives 2-3 times the muscle gains and that leucine gives an endurance benefit. This page keeps it as a report of what people, websites or other media say.

Leucine — Benefits Deep Dive

A thin upper arm, the muscle loss of sarcopenia
A thin upper arm, the muscle loss of sarcopenia
A protein-rich meal, the source of dietary leucine
A protein-rich meal, the source of dietary leucine

Leucine is the master regulator of muscle protein synthesis via mechanistic target of rapamycin complex 1 (mTORC1) activation — the single most potent dietary amino acid for triggering anabolism. Leucine functions as a direct molecular signal that switches on the cell's protein-building machinery through the Sestrin2 / GATOR2 / Rag GTPase / mTORC1 cascade, in addition to serving as a structural building block; arginine (through CASTOR1) and S-adenosylmethionine, made from methionine (through SAMTOR), have sensors of their own. Four benefit pages below explore the physiology in depth: the muscle protein synthesis mechanism and the 2.5–3 g per-meal leucine threshold, the mechanistic target of rapamycin (mTOR) amino-acid sensing pathway and its tension with rapamycin-mediated longevity, sarcopenia prevention through the Bauer PROVIDE protocol and beta-hydroxy-beta-methylbutyrate (HMB) metabolite supplementation, and the timing and dosing protocols that maximize the response to resistance exercise. A unifying theme: leucine's anabolic effect is real and clinically meaningful, particularly for the elderly with anabolic resistance and for athletes during periods of high training demand — but the same mechanistic target of rapamycin activation that builds muscle works against the autophagy and longevity programs engaged by fasting, methionine restriction, and rapamycin. Which intervention fits depends on which of those goals a person has.

Deep-Dive Articles

💪

Muscle Protein Synthesis

Leucine as the principal nutrient trigger for mTORC1 activation. The Sestrin2/GATOR2 amino-acid sensing mechanism characterized by Wolfson and colleagues at the Sabatini lab (Science 2016), the 2.5–3 g per-meal leucine threshold for maximal muscle protein synthesis, why whey protein stood above casein and soy in the post-exercise window of the Tang 2009 trial (whey hydrolysate about 122% above casein and 31% above soy isolate), the per-meal protein distribution research from Volpi, Wolfe, Paddon-Jones, and Mamerow, and the muscle-full effect that limits how often muscle protein synthesis can be re-stimulated.

Read the deep dive →
🧬

Mechanistic Target of Rapamycin Activation

The Sabatini lab amino-acid sensing program at the Whitehead Institute: Sestrin2 for leucine, CASTOR1 for arginine, SAMTOR for S-adenosylmethionine. The GATOR1/GATOR2/Rag GTPase cascade and the lysosomal recruitment of mTORC1. The rapamycin longevity paradigm, the antagonistic pairing of mechanistic target of rapamycin vs autophagy, and the tradeoff between leucine-driven anabolism and the longevity benefit of mechanistic target of rapamycin suppression — why leucine matters less in young muscle and more in elderly muscle with anabolic resistance.

Read the deep dive →
🧓

Sarcopenia Prevention

The Volpi anabolic resistance research, the Bauer PROVIDE trial of a supplement combining whey protein, leucine and vitamin D in 380 sarcopenic older adults, with no exercise program (over 13 weeks: 0.17 kg more arm and leg muscle and a chair-stand test 1.01 seconds faster than controls, with handgrip strength and the overall physical performance score, the primary outcomes, not different; the authors call it proof-of-principle), the PROT-AGE consensus recommending 1.0–1.2 g protein/kg/day with 25–30 g per meal, leucine-enriched whey supplementation in clinical practice, and the HMB (beta-hydroxy-beta-methylbutyrate) leucine metabolite research from Steve Nissen and Jeff Wilson on muscle preservation in deconditioned and elderly populations.

Read the deep dive →
🏃

Recovery & Exercise

Leucine timing across pre-workout, intra-workout, and post-workout windows. Intra-workout branched-chain amino acids (BCAAs) vs whole protein, the branched-chain ketoacid pathway in mitochondria providing acetyl-CoA fuel during prolonged exercise, the central fatigue mechanism through tryptophan competition at the blood-brain barrier, exercise-induced sensitization of muscle to protein feeding, measured for up to 24 hours in Burd 2011, and the resistance training + leucine synergy that produces 2–3 times the muscle gains of either intervention alone in older adults.

Read the deep dive →
⚡

Leucine, Mitochondria and Cell Energy

Worm and cell experiments showing leucine slows the breakdown of mitochondrial membrane proteins, through a route separate from the muscle-building mechanistic target of rapamycin pathway.

Read the deep dive →

Back to Table of Contents

Table of Contents

  1. Deep-Dive Articles
  2. Why Leucine Produces Effects Across Many Systems
  3. Research Papers: Muscle Protein Synthesis
  4. Research Papers: Mechanistic Target of Rapamycin & Longevity Tradeoff
  5. Research Papers: Sarcopenia & HMB
  6. Research Papers: Exercise & Recovery
  7. Research Papers: Cross-Cutting (Mechanism, Safety, Forms)
  8. External Authoritative Resources
  9. Connections
  10. Featured Videos

Why Leucine Produces Effects Across Many Systems

Most amino acids serve a single principal function — they are incorporated into proteins as building blocks. Leucine is unusual because it operates through three distinct biological mechanisms simultaneously, and each mechanism maps to a different category of clinical effect.

  1. Direct molecular signaling through Sestrin2 — leucine binds a deep hydrophobic pocket on the cytosolic protein Sestrin2, releasing Sestrin2's inhibition of the GATOR2 complex. This relief-of-inhibition cascade ultimately activates the Rag GTPases, which recruit mTORC1 to the lysosomal surface where it phosphorylates 4E-BP1, S6K1, and other translation-initiation factors. This is the mechanism behind muscle protein synthesis and the per-meal leucine threshold and behind the broader mTORC1-mediated anabolic program. The molecular sensing was elegantly mapped by David Sabatini's lab at the Whitehead Institute (Wolfson 2016 Science, Saxton 2016 Science).
  2. Structural incorporation as a proteinogenic amino acid — leucine is the most abundant amino acid in mammalian muscle protein (approximately 8–10% of total amino acid mass). Without adequate dietary leucine, ribosomes stall during muscle protein translation and the new protein cannot be assembled. This building-block role explains why leucine is essential to sarcopenia prevention and to exercise recovery even beyond its signaling effect — you can't make new muscle without it.
  3. Metabolic substrate through the branched-chain ketoacid pathway — leucine that exceeds protein-synthetic needs is oxidized in mitochondria via the BCKDH complex, producing acetyl-CoA (for the citric acid cycle) and acetoacetate (a ketone body). The pathway provides adenosine triphosphate (ATP) during prolonged exercise and is partially responsible for the endurance benefit of leucine during long training sessions. Leucine's metabolite HMB is produced through a parallel branch of this pathway and has its own substantial anti-catabolic activity discussed in the sarcopenia page.

Leucine taken on its own gave a different result from the combined supplement in PROVIDE. In the LACE randomized placebo-controlled trial (older adults aged 70 and over with sarcopenia, 14 UK centers, 2.5 g three times daily, 12 months; 145 people randomized against an original target of 440), leucine did not improve the physical performance score (adjusted effect 0.1 point, 95% confidence interval −1.0 to 1.1, P=0.90) or muscle mass (−0.3 kg, −1.0 to 0.4, P=0.47). Combining its results with earlier reviews, the authors did not find evidence that leucine improves physical performance.

The therapeutic complication is that the same mTORC1 signaling that builds muscle also suppresses autophagy — the cellular process of degrading damaged proteins and dysfunctional mitochondria. Loss of autophagic capacity is a hallmark of aging and a driver of neurodegeneration, cardiomyopathy, and sarcopenia itself. The rapamycin paradigm in biogerontology is built on this: pharmacologic inhibition of mTORC1 with rapamycin extends lifespan in mice, worms, and flies, primarily through restored autophagic flux. This creates a genuine tradeoff for leucine nutrition. Maximizing per-meal leucine for muscle protein synthesis necessarily means signaling against the autophagic program that drives the rapamycin longevity effect.

One common way of describing this tradeoff, rather than a formal consensus statement: in early adulthood, when sarcopenia is not yet a concern, modest mTORC1 activation paired with periodic protein restriction (fasting days, vegetarian days, restricted-feeding windows) likely captures most of the benefit of both anabolism and autophagy. In late adulthood, when sarcopenia and frailty become primary risks, the balance tips toward maximizing per-meal leucine to preserve muscle, accepting some loss of autophagic activity as the price. For adults pursuing rapamycin or methionine restriction as a longevity strategy, practitioners describe timing high-leucine meals away from the rapamycin dose with the aim of minimizing direct molecular antagonism.

Back to Table of Contents

Research Papers: Muscle Protein Synthesis

  1. Wolfson RL et al. (2016). Sestrin2 is a leucine sensor for the mTORC1 pathway. Science. — PubMed PMID: 26449471
  2. Saxton RA et al. (2016). Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway. Science. — PubMed: Saxton Sestrin2 structure
  3. Anthony JC et al. (2000). Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. Journal of Nutrition. — PubMed: Anthony rapamycin pathway
  4. Volpi E et al. (2003). Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults. American Journal of Clinical Nutrition. — PubMed: Volpi essential amino acids
  5. Norton LE et al. (2009). The leucine content of a complete meal directs peak activation but not duration of skeletal muscle protein synthesis. Journal of Nutrition. — PubMed: Norton leucine threshold
  6. Moore DR et al. (2009). Ingested protein dose response of muscle and albumin protein synthesis after resistance exercise in young men. American Journal of Clinical Nutrition. — PubMed: Moore dose-response
  7. Tang JE et al. (2009). Ingestion of whey hydrolysate, casein, or soy protein isolate: effects on mixed muscle protein synthesis at rest and following resistance exercise in young men. Journal of Applied Physiology. — PubMed PMID: 19589961
  8. Mamerow MM et al. (2014). Dietary protein distribution positively influences 24-h muscle protein synthesis. Journal of Nutrition. — PubMed: Mamerow even distribution
  9. Atherton PJ et al. (2010). Muscle full effect after oral protein: time-dependent concordance and discordance between human muscle protein synthesis and mTORC1 signaling. American Journal of Clinical Nutrition. — PubMed PMID: 20844073
  10. Boirie Y et al. (1997). Slow and fast dietary proteins differently modulate postprandial protein accretion. PNAS. — PubMed: Boirie slow vs fast protein

Back to Table of Contents

Research Papers: Mechanistic Target of Rapamycin & Longevity Tradeoff

  1. Saxton RA, Sabatini DM (2017). mTOR signaling in growth, metabolism, and disease. Cell. — PubMed: Saxton/Sabatini review
  2. Chantranupong L et al. (2016). The CASTOR proteins are arginine sensors for the mTORC1 pathway. Cell. — PubMed: CASTOR arginine sensor
  3. Gu X et al. (2017). SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway. Science. — PubMed: SAMTOR SAM sensor
  4. Harrison DE et al. (2009). Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. — PubMed: Harrison rapamycin lifespan
  5. Sancak Y et al. (2008). The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science. — PubMed: Rag GTPases Raptor
  6. Kim J et al. (2011). AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature Cell Biology. — PubMed: AMPK/mTOR/ULK1
  7. Mannick JB et al. (2014). mTOR inhibition improves immune function in the elderly. Science Translational Medicine. — PubMed: Mannick mTOR immunity
  8. Levine ME et al. (2014). Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metabolism. — PubMed: Levine protein-IGF1-cancer
  9. Settembre C et al. (2012). A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO Journal. — PubMed: TFEB autophagy
  10. Solon-Biet SM et al. (2014). The ratio of macronutrients, not caloric intake, dictates cardiometabolic health, aging, and longevity in ad libitum-fed mice. Cell Metabolism. — PubMed: Solon-Biet macronutrient ratio

Back to Table of Contents

Research Papers: Sarcopenia & HMB

  1. Bauer JM et al. (2015). Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study. JAMDA. — PubMed PMID: 26170041
  2. Bauer J et al. (2013). Evidence-based recommendations for optimal dietary protein intake in older people: PROT-AGE Study Group. JAMDA. — PubMed: PROT-AGE consensus
  3. Cruz-Jentoft AJ et al. (2019). Sarcopenia: revised European consensus on definition and diagnosis (EWGSOP2). Age and Ageing. — PubMed: EWGSOP2 criteria
  4. Cuthbertson D et al. (2005). Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB Journal. — PubMed: Cuthbertson anabolic resistance
  5. Wilson JM et al. (2013). International Society of Sports Nutrition Position Stand: beta-hydroxy-beta-methylbutyrate (HMB). Journal of the International Society of Sports Nutrition. — PubMed: Wilson ISSN HMB position
  6. Nissen S et al. (1996). Effect of leucine metabolite beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistance-exercise training. Journal of Applied Physiology. — PubMed: Nissen HMB original
  7. Deutz NEP et al. (2013). Effect of beta-hydroxy-beta-methylbutyrate (HMB) on lean body mass during 10 days of bed rest in older adults. Clinical Nutrition. — PubMed: Deutz HMB bed rest
  8. Fiatarone MA et al. (1990). High-intensity strength training in nonagenarians. JAMA. — PubMed: Fiatarone nonagenarians
  9. Tieland M et al. (2012). Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people. Journal of the American Medical Directors Association. — PubMed PMID: 22770932
  10. Achison M et al. (2022). Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial. Journal of Cachexia, Sarcopenia and Muscle. — PubMed PMID: 35174663
  11. Rondanelli M et al. (2016). Whey protein, amino acids, and vitamin D supplementation with physical activity increases fat-free mass in elderly with sarcopenia. American Journal of Clinical Nutrition. — PubMed: Rondanelli whey + vitamin D

Back to Table of Contents

Research Papers: Exercise & Recovery

  1. Tipton KD et al. (2001). Timing of amino acid-carbohydrate ingestion alters anabolic response of muscle to resistance exercise. American Journal of Physiology. — PubMed: Tipton timing
  2. Burd NA et al. (2011). Enhanced amino acid sensitivity of myofibrillar protein synthesis persists for up to 24 h after resistance exercise in young men. Journal of Nutrition. — PubMed PMID: 21289204
  3. Dreyer HC et al. (2006). Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle. Journal of Physiology. — PubMed PMID: 16873412
  4. Schoenfeld BJ et al. (2013). The effect of protein timing on muscle strength and hypertrophy: meta-analysis. JISSN. — PubMed: Schoenfeld timing meta-analysis
  5. Wolfe RR (2017). Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? JISSN. — PubMed: Wolfe BCAA myth
  6. Areta JL et al. (2013). Timing and distribution of protein ingestion during prolonged recovery from resistance exercise. Journal of Physiology. — PubMed: Areta distribution
  7. Res PT et al. (2012). Protein ingestion before sleep improves postexercise overnight recovery. MSSE. — PubMed: Res pre-sleep casein
  8. Watson P et al. (2004). Effect of acute branched-chain amino acid supplementation on prolonged exercise capacity. European Journal of Applied Physiology. — PubMed: Watson BCAA endurance
  9. Phillips SM (2014). A brief review of critical processes in exercise-induced muscular hypertrophy. Sports Medicine. — PubMed: Phillips hypertrophy
  10. Newsholme EA et al. (1991). Amino acids, brain neurotransmitters and a link between muscle and brain in sustained exercise. Advances in Myochemistry. — PubMed: Newsholme central fatigue
  11. Wilson JM et al. (2014). 12 weeks of HMB free acid supplementation on muscle mass, strength, and power in resistance-trained individuals. European Journal of Applied Physiology. — PubMed: Wilson HMB-FA trained

Back to Table of Contents

Research Papers: Cross-Cutting (Mechanism, Safety, Forms)

  1. Layman DK (2003). The role of leucine in weight loss diets and glucose homeostasis. Journal of Nutrition. — PubMed: Layman leucine review
  2. Paddon-Jones D, Rasmussen BB (2009). Dietary protein recommendations and the prevention of sarcopenia. Current Opinion in Clinical Nutrition. — PubMed: Paddon-Jones protein
  3. Reidy PT, Rasmussen BB (2016). Role of ingested amino acids and protein in resistance exercise-induced muscle anabolism. Journal of Nutrition. — PubMed: Reidy/Rasmussen review
  4. Wagenmakers AJ (1998). Muscle amino acid metabolism at rest and during exercise. Exercise and Sport Sciences Reviews. — PubMed: Wagenmakers BCAA oxidation
  5. Layman DK et al. (2015). Defining meal requirements for protein to optimize metabolic roles of amino acids. American Journal of Clinical Nutrition. — PubMed: Layman per-meal requirements
  6. Pencharz PB et al. (2016). Recent developments in understanding protein needs — how much and what kind. Applied Physiology, Nutrition, and Metabolism. — PubMed: Pencharz protein needs
  7. Holecek M (2018). Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements. Nutrition & Metabolism. — PubMed: Holecek BCAA review
  8. Strawford A et al. (1999). Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss. JAMA. (An androgen trial, listed as context on muscle wasting; it did not test leucine.) — PubMed PMID: 10208143
  9. Witard OC et al. (2014). Myofibrillar muscle protein synthesis rates subsequent to a meal in response to increasing doses of whey protein. American Journal of Clinical Nutrition. — PubMed: Witard whey dose-response

Back to Table of Contents

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents